Identification by virtual screening of protein tyrosine phosphatase 1B and matrix metalloproteinase 13 inhibitors for the treatment of obesity and obesity-associated disorders

Identificador:  TDX:2923

Handle: https://hdl.handle.net/20.500.11797/TDX2923

Autors:  Gimeno Vives, Aleix

Resum:
Obesity is one of the major public health problems in the 21st century. The great economic expansion of the last decades in developed countries has contributed to the increased consumption of unhealthy foods and the excessive usage of energy-saving technologies. These have in turn led to the development of unhealthy lifestyles and the consequent increase of obesity prevalence. Thus, obesity has emerged as a natural response to an unnatural environment. With the continuous increase in obese population in each generation, the prevalence of obesity-associated disorders such as type II diabetes and osteoarthritis is also on the rise, and the prospect of developing a medical therapy specific for each patient earns increasing interest. In this regard, the targets protein tyrosine phosphatase 1B (PTP1B) and matrix metalloproteinase 13 (MMP-13) are involved in both obesity and, respectively, type II diabetes mellitus and osteoarthritis. The present doctoral thesis focuses on developing virtual screening strategies to identify compounds that modulate the activity of these two targets which may have a positive influence on both obesity and its associated disorders.